BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 16951162)

  • 1. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
    Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
    Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation.
    Zhang G; Zhou J; Fan Q; Zheng Z; Zhang F; Liu X; Hu S
    FEBS Lett; 2008 Aug; 582(19):2957-64. PubMed ID: 18671974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice.
    Vincent F; Bonnin P; Clemessy M; Contrerès JO; Lamandé N; Gasc JM; Vilar J; Hainaud P; Tobelem G; Corvol P; Dupuy E
    Cancer Res; 2009 Apr; 69(7):2853-60. PubMed ID: 19318581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.
    Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL
    Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
    Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
    Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting.
    Lobov IB; Renard RA; Papadopoulos N; Gale NW; Thurston G; Yancopoulos GD; Wiegand SJ
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3219-24. PubMed ID: 17296940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
    Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
    Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling.
    van den Akker NM; Caolo V; Wisse LJ; Peters PP; Poelmann RE; Carmeliet P; Molin DG; Gittenberger-de Groot AC
    Cardiovasc Res; 2008 May; 78(2):366-75. PubMed ID: 18093989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.
    Gale NW; Baluk P; Pan L; Kwan M; Holash J; DeChiara TM; McDonald DM; Yancopoulos GD
    Dev Biol; 2001 Feb; 230(2):151-60. PubMed ID: 11161569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling.
    Huang MT; Dai YS; Chou YB; Juan YH; Wang CC; Chiang BL
    J Immunol; 2009 Oct; 183(7):4745-54. PubMed ID: 19752226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization.
    Hayashi S; Asahara T; Masuda H; Isner JM; Losordo DW
    Circulation; 2005 May; 111(17):2210-8. PubMed ID: 15851594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature.
    Maekawa H; Oike Y; Kanda S; Ito Y; Yamada Y; Kurihara H; Nagai R; Suda T
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2008-14. PubMed ID: 14500293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
    Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
    Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Delta-like 4 ligand/Notch-ephrin-B2 cascade in the pathogenesis of preeclampsia by regulating functions of endothelial progenitor cell.
    Liu X; Luo Q; Zheng Y; Liu X; Hu Y; Wang F; Zou L
    Placenta; 2015 Sep; 36(9):1002-10. PubMed ID: 26212082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.
    Brantley DM; Cheng N; Thompson EJ; Lin Q; Brekken RA; Thorpe PE; Muraoka RS; Cerretti DP; Pozzi A; Jackson D; Lin C; Chen J
    Oncogene; 2002 Oct; 21(46):7011-26. PubMed ID: 12370823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.
    Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M
    Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
    Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
    Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly.
    Foo SS; Turner CJ; Adams S; Compagni A; Aubyn D; Kogata N; Lindblom P; Shani M; Zicha D; Adams RH
    Cell; 2006 Jan; 124(1):161-73. PubMed ID: 16413489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.